{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:28:57Z","timestamp":1782217737656,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Fifth Batch of National Traditional Chinese Medicine Excellent Clinical Talents Training Project.","award":["Announcement from the Personnel and Education Department of the National Administration of Traditional Chinese Medicine. No. 2022-1"],"award-info":[{"award-number":["Announcement from the Personnel and Education Department of the National Administration of Traditional Chinese Medicine. No. 2022-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Numerous long noncoding RNAs (lncRNAs) have been proven to participate in osteogenesis and postmenopausal osteoporosis (PMOP). We measured serum SDCBP2-AS1 expression changes in patients with PMOP and investigated its effects on osteoblast differentiation in human bone marrow-derived mesenchymal stem cells (hBMSC) cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>RT-qPCR was used to measure SDCBP2-AS1 levels and the expression of osteogenic differentiation indicators. The diagnostic efficacy of SDCBP2-AS1 was assessed using a receiver operating characteristic (ROC) analysis. CCK-8 and flow cytometry methods were employed to investigate the functional impact of SDCBP2-AS1 on hBMSC cell proliferation and apoptosis during osteoblast differentiation. The bioinformatics, dual-luciferase reporter assay, and RNA Immunoprecipitation (RIP) assay were used to identify and confirm SDCBP2-AS1\/miR-361-3p interaction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Serum SDCBP2-AS1 was decreased in patients with PMOP, especially in those with fractures. The SDCBP2-AS1 levels were positively correlated with patients\u2019 T scores and BMDs. Decreased SDCBP2-AS1 had a certain high area under the ROC curve (AUC) value (AUC\u2009=\u20090.81) in distinguishing PMOP patients with fractures from those without fractures. SDCBP2-AS1 levels gradually increased after four weeks of treatment in PMOP patients and hBMSCs during cell differentiation. Enhanced SDCBP2-AS1 promoted cell proliferation and the levels of osteoblast differentiation markers, including ALP, OCN, RUNX2, and Collagen I, while decreasing cell apoptosis. miR-361-3p was a direct target of SDCBP2-AS1. The influence of SDCBP2-AS1 on cell activities and hBMSCs differentiation was diminished by miR-361-3p.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>SDCBP2-AS1 might be a diagnostic biomarker in predicting PMOP patients with fractures. By measuring the levels of SDCBP2-AS1 in patient samples, clinicians may be able to identify those who are more susceptible to bone fractures, enabling earlier and more targeted preventive measures. SDCBP2-AS1 targeting miR-361-3p regulates the osteogenic differentiation of hBMSCs, which might be a new target for the treatment of PMOP.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00494-5","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:51:18Z","timestamp":1752155478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LncRNA SDCBP2-AS1 is a putative biomarker for postmenopausal osteoporosis and promotes osteogenic differentiation of BMSCs by regulating miR-361-3p"],"prefix":"10.1186","volume":"162","author":[{"given":"Jindong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"3","key":"494_CR1","first-page":"544","volume":"36","author":"JP Brown","year":"2021","unstructured":"Brown JP, Long-Term Treatment of Postmenopausal Osteoporosis. Seoul. Korea). 2021;36(3):544\u201352.","journal-title":"Korea)"},{"issue":"4","key":"494_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ecl.2024.08.008","volume":"53","author":"P Subarajan","year":"2024","unstructured":"Subarajan P, Arceo-Mendoza RM, Camacho PM. Postmenopausal osteoporosis: A review of latest guidelines. Endocrinol Metab Clin North Am. 2024;53(4):497\u2013512.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Pt 1","key":"494_CR3","doi-asserted-by":"publisher","first-page":"143497","DOI":"10.1016\/j.ijbiomac.2025.143497","volume":"311","author":"S Gao","year":"2025","unstructured":"Gao S, Xu T, Wang W, Li J, Shan Y, Wang Y, et al. Polysaccharides from anemarrhena asphodeloides bge, the extraction, purification, structure characterization, biological activities and application of a traditional herbal medicine. Int J Biol Macromol. 2025;311(Pt 1):143497.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"494_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1530\/EOR-23-0205","volume":"9","author":"DT Arthur Vithran","year":"2024","unstructured":"Arthur Vithran DT, Essien AE, Rahmati M, Opoku M, Keon Yon D, L\u00f3pez S\u00e1nchez GF, et al. Teriparatide in postmenopausal osteoporosis: Uncovering novel insights into efficacy and safety compared to other treatments - a systematic review and meta-analysis. EFORT Open Reviews. 2024;9(9):845\u201361.","journal-title":"EFORT Open Reviews"},{"issue":"1","key":"494_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1186\/s13018-024-05288-5","volume":"19","author":"L Li","year":"2024","unstructured":"Li L, Wang Y, Fan T, Fan T. Efficacy of traditional Chinese exercise on postmenopausal osteoporosis: a systematic review and meta-analysis. J Orthop Surg Res. 2024;19(1):785.","journal-title":"J Orthop Surg Res"},{"issue":"6","key":"494_CR6","doi-asserted-by":"publisher","first-page":"101551","DOI":"10.1016\/j.beem.2021.101551","volume":"35","author":"A Gosset","year":"2021","unstructured":"Gosset A, Pouill\u00e8s JM, Tr\u00e9mollieres F. Menopausal hormone therapy for the management of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101551.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"494_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/17512433.2021.1851192","volume":"14","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Colarossi G, Baroncini A, Eschweiler J, Tingart M, Maffulli N. Pharmacological management of postmenopausal osteoporosis: a level I evidence Based - Expert opinion. Expert Rev Clin Pharmacol. 2021;14(1):105\u201319.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"494_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/bmb\/ldac017","volume":"143","author":"F Migliorini","year":"2022","unstructured":"Migliorini F, Colarossi G, Eschweiler J, Oliva F, Driessen A, Maffulli N. Antiresorptive treatments for corticosteroid-induced osteoporosis: a bayesian network meta-analysis. Br Med Bull. 2022;143(1):46\u201356.","journal-title":"Br Med Bull"},{"issue":"6","key":"494_CR9","doi-asserted-by":"publisher","first-page":"e31286","DOI":"10.1002\/jcp.31286","volume":"239","author":"B Jiang","year":"2024","unstructured":"Jiang B, Zheng J, Yao H, Wang Y, Song F, Huang C. IRX5 suppresses osteogenic differentiation of hBMSCs by inhibiting protein synthesis. J Cell Physiol. 2024;239(6):e31286.","journal-title":"J Cell Physiol"},{"issue":"1","key":"494_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13018-023-03538-6","volume":"18","author":"Y Lin","year":"2023","unstructured":"Lin Y, Dai H, Yu G, Song C, Liu J, Xu J. Inhibiting KCNMA1-AS1 promotes osteogenic differentiation of HBMSCs via miR-1303\/cochlin axis. J Orthop Surg Res. 2023;18(1):73.","journal-title":"J Orthop Surg Res"},{"key":"494_CR11","doi-asserted-by":"publisher","first-page":"903278","DOI":"10.3389\/fcell.2022.903278","volume":"10","author":"X Chen","year":"2022","unstructured":"Chen X, Xie W, Zhang M, Shi Y, Xu S, Cheng H, et al. The emerging role of Non-Coding RNAs in osteogenic differentiation of human bone marrow mesenchymal stem cells. Front Cell Dev Biology. 2022;10:903278.","journal-title":"Front Cell Dev Biology"},{"issue":"23","key":"494_CR12","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2217\/epi-2023-0242","volume":"15","author":"H Haybar","year":"2023","unstructured":"Haybar H, Sadati NS, Purrahman D, Mahmoudian-Sani MR, Saki N. LncRNA TUG1 as potential novel biomarker for prognosis of cardiovascular diseases. Epigenomics. 2023;15(23):1273\u201390.","journal-title":"Epigenomics"},{"issue":"5","key":"494_CR13","first-page":"4518","volume":"16","author":"Q Wan","year":"2024","unstructured":"Wan Q, Deng Y, Wei R, Ma K, Tang J, Deng YP. Tumor-infiltrating macrophage associated LncRNA signature in cutaneous melanoma: implications for diagnosis, prognosis, and immunotherapy. Aging. 2024;16(5):4518\u201340.","journal-title":"Aging"},{"issue":"1","key":"494_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/bmb\/ldaa002","volume":"133","author":"L Giordano","year":"2020","unstructured":"Giordano L, Porta GD, Peretti GM, Maffulli N. Therapeutic potential of MicroRNA in tendon injuries. Br Med Bull. 2020;133(1):79\u201394.","journal-title":"Br Med Bull"},{"issue":"1","key":"494_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/bmb\/ldaa040","volume":"138","author":"G Gargano","year":"2021","unstructured":"Gargano G, Oliviero A, Oliva F, Maffulli N. Small interfering RNAs in tendon homeostasis. Br Med Bull. 2021;138(1):58\u201367.","journal-title":"Br Med Bull"},{"issue":"1","key":"494_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/bmb\/ldz015","volume":"130","author":"A Oliviero","year":"2019","unstructured":"Oliviero A, Della Porta G, Peretti GM, Maffulli N. MicroRNA in osteoarthritis: physiopathology, diagnosis and therapeutic challenge. Br Med Bull. 2019;130(1):137\u201347.","journal-title":"Br Med Bull"},{"issue":"1","key":"494_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/bmb\/ldad023","volume":"148","author":"G Gargano","year":"2023","unstructured":"Gargano G, Asparago G, Spiezia F, Oliva F, Maffulli N. Small interfering RNAs in the management of human osteoporosis. Br Med Bull. 2023;148(1):58\u201369.","journal-title":"Br Med Bull"},{"issue":"1","key":"494_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/bmb\/ldac012","volume":"142","author":"G Gargano","year":"2022","unstructured":"Gargano G, Oliva F, Oliviero A, Maffulli N. Small interfering RNAs in the management of human rheumatoid arthritis. Br Med Bull. 2022;142(1):34\u201343.","journal-title":"Br Med Bull"},{"issue":"6","key":"494_CR19","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s00774-020-01123-z","volume":"38","author":"L Zhang","year":"2020","unstructured":"Zhang L, Xie H, Li S. LncRNA LOXL1-AS1 controls osteogenic and adipocytic differentiation of bone marrow mesenchymal stem cells in postmenopausal osteoporosis through regulating the miR-196a-5p\/Hmga2 axis. J Bone Miner Metab. 2020;38(6):794\u2013805.","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"494_CR20","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/s41598-023-29546-4","volume":"13","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhang H, Li Q, Zhang L, Chen L, Wang H, et al. Long non-coding RNA KCNQ1OT1 alleviates postmenopausal osteoporosis by modulating miR-421-3p\/mTOR axis. Sci Rep. 2023;13(1):2333.","journal-title":"Sci Rep"},{"key":"494_CR21","doi-asserted-by":"publisher","first-page":"1195840","DOI":"10.3389\/fnins.2023.1195840","volume":"17","author":"N Gil-Jaramillo","year":"2023","unstructured":"Gil-Jaramillo N, Aristiz\u00e1bal-Pach\u00f3n AF, Luque Aleman MA, Gonz\u00e1lez G\u00f3mez V, Escobar Hurtado HD, Gir\u00f3n Pinto LC, et al. Competing endogenous RNAs in human astrocytes: crosstalk and interacting networks in response to lipotoxicity. Front NeuroSci. 2023;17:1195840.","journal-title":"Front NeuroSci"},{"issue":"1","key":"494_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12957-021-02295-2","volume":"19","author":"X Liu","year":"2021","unstructured":"Liu X, Liu C, Zhang A, Wang Q, Ge J, Li Q, et al. Long non-coding RNA SDCBP2-AS1 delays the progression of ovarian cancer via microRNA-100-5p-targeted EPDR1. World J Surg Oncol. 2021;19(1):199.","journal-title":"World J Surg Oncol"},{"key":"494_CR23","doi-asserted-by":"crossref","unstructured":"Centofanti F, Santoro M, Marini M, Visconti VV, Rinaldi AM, Celi M et al. Identification of Aberrantly-Expressed long Non-Coding RNAs in osteoblastic cells from osteoporotic patients. Biomedicines. 2020;8(3):65.","DOI":"10.3390\/biomedicines8030065"},{"key":"494_CR24","doi-asserted-by":"crossref","unstructured":"Ito S, Minamizaki T, Kohno S, Sotomaru Y, Kitaura Y, Ohba S et al. Overexpression of miR-125b in osteoblasts improves Age-Related changes in bone mass and quality through suppression of osteoclast formation. Int J Mol Sci. 2021;22(13).","DOI":"10.3390\/ijms22136745"},{"issue":"8","key":"494_CR25","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/jbmr.4834","volume":"38","author":"Y Xie","year":"2023","unstructured":"Xie Y, Zhou J, Tian L, Dong Y, Yuan H, Zhu E, et al. miR-196b-5p regulates osteoblast and osteoclast differentiation and bone homeostasis by targeting SEMA3A. J Bone Mineral Research: Official J Am Soc Bone Mineral Res. 2023;38(8):1175\u201391.","journal-title":"J Bone Mineral Research: Official J Am Soc Bone Mineral Res"},{"issue":"12","key":"494_CR26","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.1093\/nar\/gkac524","volume":"50","author":"JH Yang","year":"2022","unstructured":"Yang JH, Chang MW, Tsitsipatis D, Yang X, Martindale JL, Munk R, et al. LncRNA OIP5-AS1-directed miR-7 degradation promotes MYMX production during human myogenesis. Nucleic Acids Res. 2022;50(12):7115\u201333.","journal-title":"Nucleic Acids Res"},{"key":"494_CR27","doi-asserted-by":"crossref","unstructured":"Yang X, Chen H, Zheng H, Chen K, Cai P, Li L et al. LncRNA SNHG12 promotes osteoarthritis progression through targeted Down-Regulation of miR-16-5p. Clin Lab. 2022;68(1).","DOI":"10.7754\/Clin.Lab.2021.210402"},{"issue":"2","key":"494_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10735-021-10049-3","volume":"53","author":"X Ye","year":"2022","unstructured":"Ye X, Song H, Hu H, Zhou C, Chen Q, Hong L, et al. MiR-361-3p alleviates cerebral ischemia-reperfusion injury by targeting NACC1 through the PINK1\/Parkin pathway. J Mol Histol. 2022;53(2):357\u201367.","journal-title":"J Mol Histol"},{"key":"494_CR29","doi-asserted-by":"crossref","unstructured":"Zamarbide Losada JN, Sulpice E, Combe S, Almeida GS, Leach DA, Choo J et al. Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer. J Endocrinol. 2023;256(3):e220229.","DOI":"10.1530\/JOE-22-0229"},{"issue":"2","key":"494_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11626-021-00644-9","volume":"58","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhou X, Sun J, Li M, Ma J, Ge L. miR-361-3p mitigates hypoxia-induced cardiomyocyte injury via targeting apoptosis initiators caspase-2\/-8\/-9. Vitro Cell Dev Biology Anim. 2022;58(2):116\u201323.","journal-title":"Vitro Cell Dev Biology Anim"},{"issue":"10","key":"494_CR31","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1177\/0022034519864519","volume":"98","author":"HQ Liao","year":"2019","unstructured":"Liao HQ, Liu H, Sun HL, Xiang JB, Wang XX, Jiang CX, et al. MiR-361-3p\/Nfat5 signaling Axis controls cementoblast differentiation. J Dent Res. 2019;98(10):1131\u20139.","journal-title":"J Dent Res"},{"key":"494_CR32","doi-asserted-by":"publisher","first-page":"9093614","DOI":"10.1155\/2022\/9093614","volume":"2022","author":"L Li","year":"2022","unstructured":"Li L, Ayiding X, Han R. miRNA-Gene interaction network construction strategy to discern promising traditional Chinese medicine against osteoporosis. Biomed Res Int. 2022;2022:9093614.","journal-title":"Biomed Res Int"},{"key":"494_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2017.07.071","volume":"94","author":"Z Wu","year":"2017","unstructured":"Wu Z, Ou L, Wang C, Yang L, Wang P, Liu H, et al. Icaritin induces MC3T3-E1 subclone14 cell differentiation through Estrogen receptor-mediated ERK1\/2 and p38 signaling activation. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2017;94:1\u20139.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"494_CR34","doi-asserted-by":"publisher","first-page":"105626","DOI":"10.1016\/j.jff.2023.105626","volume":"107","author":"C Peng","year":"2023","unstructured":"Peng C, Feng Z, Ou L, Zou Y, Sang S, Liu H, et al. Syzygium aromaticum enhances innate immunity by triggering macrophage M1 polarization and alleviates Helicobacter pylori-induced inflammation. J Funct Foods. 2023;107:105626.","journal-title":"J Funct Foods"},{"issue":"Database issue","key":"494_CR35","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. StarBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"494_CR36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10142-024-01443-7","volume":"24","author":"H Liu","year":"2024","unstructured":"Liu H, Weng J, Huang CL, Jackson AP. Is the voltage-gated sodium channel \u03b23 subunit (SCN3B) a biomarker for glioma? Funct Integr Genom. 2024;24(5):162.","journal-title":"Funct Integr Genom"},{"key":"494_CR37","doi-asserted-by":"publisher","first-page":"146325","DOI":"10.1016\/j.gene.2022.146325","volume":"822","author":"H Liu","year":"2022","unstructured":"Liu H, Weng J. A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma. Gene. 2022;822:146325.","journal-title":"Gene"},{"issue":"3\u20134","key":"494_CR38","first-page":"Cbm240119","volume":"41","author":"AM Rasteh","year":"2024","unstructured":"Rasteh AM, Liu H, Wang P. Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases. Cancer Biomark A. 2024;41(3\u20134):Cbm240119.","journal-title":"Cancer Biomark A"},{"key":"494_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278\u2013279","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278\u2013279:91\u2013103.","journal-title":"Cancer Genet"},{"issue":"8","key":"494_CR40","first-page":"4074","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H. Pan-cancer profiles of the Cuproptosis gene set. Am J cancer Res. 2022;12(8):4074\u201381.","journal-title":"Am J cancer Res"},{"issue":"1","key":"494_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12094-022-02943-3","volume":"25","author":"J Lu","year":"2023","unstructured":"Lu J, Zhu D, Zhang X, Wang J, Cao H, Li L. The crucial role of LncRNA MIR210HG involved in the regulation of human cancer and other disease. Clin Translational Oncology: Official Publication Federation Span Oncol Soc Natl Cancer Inst Mexico. 2023;25(1):137\u201350.","journal-title":"Clin Translational Oncology: Official Publication Federation Span Oncol Soc Natl Cancer Inst Mexico"},{"issue":"2","key":"494_CR42","doi-asserted-by":"publisher","first-page":"103432","DOI":"10.1016\/j.drudis.2022.103432","volume":"28","author":"J Yan","year":"2023","unstructured":"Yan J, Wang R, Tan J. Recent advances in predicting lncRNA-disease associations based on computational methods. Drug Discovery Today. 2023;28(2):103432.","journal-title":"Drug Discovery Today"},{"issue":"1","key":"494_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/1871530319666190904161707","volume":"20","author":"D Li","year":"2020","unstructured":"Li D, Yang C, Yin C, Zhao F, Chen Z, Tian Y, et al. LncRNA, important player in bone development and disease. Endocr Metab Immune Disord Drug Targets. 2020;20(1):50\u201366.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"494_CR44","doi-asserted-by":"publisher","first-page":"1210627","DOI":"10.3389\/fendo.2023.1210627","volume":"14","author":"F An","year":"2023","unstructured":"An F, Wang X, Wang C, Liu Y, Sun B, Zhang J, et al. Research progress on the role of lncRNA-miRNA networks in regulating adipogenic and osteogenic differentiation of bone marrow mesenchymal stem cells in osteoporosis. Front Endocrinol. 2023;14:1210627.","journal-title":"Front Endocrinol"},{"issue":"1","key":"494_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12015-022-10408-x","volume":"19","author":"B Li","year":"2023","unstructured":"Li B, Wang J, Xu F, Wang Q, Liu Q, Wang G, et al. LncRNA RAD51-AS1 regulates human bone marrow mesenchymal stem cells via interaction with YBX1 to ameliorate osteoporosis. Stem Cell Reviews Rep. 2023;19(1):170\u201387.","journal-title":"Stem Cell Reviews Rep"},{"issue":"9","key":"494_CR46","first-page":"189","volume":"69","author":"N Dai","year":"2023","unstructured":"Dai N, Ma H, Feng Y. Silencing of long non-coding RNA SDCBP2-AS1\/microRNA-656-3p\/CRIM1 axis promotes ferroptosis of lung cancer cells. Cellular and molecular biology. France). 2023;69(9):189\u201394. (Noisy-le-Grand.","journal-title":"France)"},{"issue":"11","key":"494_CR47","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/cac2.12367","volume":"42","author":"J Han","year":"2022","unstructured":"Han J, Nie M, Chen C, Cheng X, Guo T, Huangfu L, et al. SDCBP-AS1 destabilizes \u03b2-catenin by regulating ubiquitination and sumoylation of HnRNP K to suppress gastric tumorigenicity and metastasis. Cancer Commun (London England). 2022;42(11):1141\u201361.","journal-title":"Cancer Commun (London England)"},{"key":"494_CR48","doi-asserted-by":"publisher","first-page":"101759","DOI":"10.1016\/j.tice.2022.101759","volume":"76","author":"D Zhou","year":"2022","unstructured":"Zhou D, Ji G, Wei G, Li Z, Yu N, Wang Y, et al. MiR-361-3p promotes tumorigenesis of osteosarcoma cells via targeting ARID3A. Tissue Cell. 2022;76:101759.","journal-title":"Tissue Cell"},{"key":"494_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jep.2018.04.035","volume":"221","author":"H Liu","year":"2018","unstructured":"Liu H, Xiong Y, Wang H, Yang L, Wang C, Liu X, et al. Effects of water extract from epimedium on neuropeptide signaling in an ovariectomized osteoporosis rat model. J Ethnopharmacol. 2018;221:126\u201336.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"494_CR50","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3892\/etm.2017.4128","volume":"13","author":"H Liu","year":"2017","unstructured":"Liu H, Xiong Y, Zhu X, Gao H, Yin S, Wang J, et al. Icariin improves osteoporosis, inhibits the expression of PPAR\u03b3, C\/EBP\u03b1, FABP4 mRNA, N1ICD and jagged1 proteins, and increases Notch2 mRNA in ovariectomized rats. Experimental Therapeutic Med. 2017;13(4):1360\u20138.","journal-title":"Experimental Therapeutic Med"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00494-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00494-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00494-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:56:02Z","timestamp":1757231762000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00494-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00494-5","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures used in this study adhere to the tenets of the Declaration of Helsinki. All individuals involved in the study were advised of its objectives and provided signed consent forms. The research protocol received ethical clearance from the Ethics Committee at The First Affiliated Hospital of Xiamen University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}